Serial Tumor-Agnostic Plasma Profiling with a Compact NGS Panel During First-Line Therapy for Newly Diagnosed Metastatic Colorectal Cancer.
Compact tumor-agnostic plasma sequencing provides complementary molecular information, but its clinical utility requires further validation.